These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 11311470)
1. Involvement of disregulated c-myc but not c-sis/PDGF in atypical and anaplastic meningiomas. Nagashima G; Aoyagi M; Yamamoto S; Wakimoto H; Tamaki M; Yamamoto K; Fujimoto T; Hirakawa K Clin Neurol Neurosurg; 2001 Apr; 103(1):13-8. PubMed ID: 11311470 [TBL] [Abstract][Full Text] [Related]
2. Expression of PDGF and its receptor as well as their relationship to proliferating activity and apoptosis of meningiomas in human meningiomas. Yang SY; Xu GM J Clin Neurosci; 2001 May; 8 Suppl 1():49-53. PubMed ID: 11386826 [TBL] [Abstract][Full Text] [Related]
3. Different distribution of c-myc and MIB-1 positive cells in malignant meningiomas with reference to TGFs, PDGF, and PgR expression. Nagashima G; Asai J; Suzuki R; Fujimoto T Brain Tumor Pathol; 2001; 18(1):1-5. PubMed ID: 11517968 [TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor expression and stimulation in human meningiomas. Black PM; Carroll R; Glowacka D; Riley K; Dashner K J Neurosurg; 1994 Sep; 81(3):388-93. PubMed ID: 8057146 [TBL] [Abstract][Full Text] [Related]
5. Expression of c-Myc, neurofibromatosis Type 2, somatostatin receptor 2 and erb-B2 in human meningiomas: relation to grades or histotypes. Durand A; Champier J; Jouvet A; Labrousse F; Honnorat J; Guyotat J; Fèvre-Montange M Clin Neuropathol; 2008; 27(5):334-45. PubMed ID: 18808065 [TBL] [Abstract][Full Text] [Related]
6. Human meningiomas co-express platelet-derived growth factor (PDGF) and PDGF-receptor genes and their protein products. Maxwell M; Galanopoulos T; Hedley-Whyte ET; Black PM; Antoniades HN Int J Cancer; 1990 Jul; 46(1):16-21. PubMed ID: 2163990 [TBL] [Abstract][Full Text] [Related]
7. Correlation of proto-oncogene expression and proliferation and meningiomas. Detta A; Kenny BG; Smith C; Logan A; Hitchcock E Neurosurgery; 1993 Dec; 33(6):1065-74. PubMed ID: 8133992 [TBL] [Abstract][Full Text] [Related]
8. Proliferation and DNA fragmentation in meningioma subtypes. Maier H; Wanschitz J; Sedivy R; Rössler K; Ofner D; Budka H Neuropathol Appl Neurobiol; 1997 Dec; 23(6):496-506. PubMed ID: 9460716 [TBL] [Abstract][Full Text] [Related]
9. [Expression of HER2/neu in meningiomas: an immunohistochemistry and fluorescence in situ hybridization study]. Wang CL; Mei JH; Wang SS; Xu S; Xu LL; Xiong YF Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):156-60. PubMed ID: 20450760 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas. Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227 [TBL] [Abstract][Full Text] [Related]
11. Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics. Kolles H; Niedermayer I; Schmitt C; Henn W; Feld R; Steudel WI; Zang KD; Feiden W Acta Neurochir (Wien); 1995; 137(3-4):174-81. PubMed ID: 8789658 [TBL] [Abstract][Full Text] [Related]
12. Comparative proteomic profiles of meningioma subtypes. Okamoto H; Li J; Vortmeyer AO; Jaffe H; Lee YS; Gläsker S; Sohn TS; Zeng W; Ikejiri B; Proescholdt MA; Mayer C; Weil RJ; Oldfield EH; Zhuang Z Cancer Res; 2006 Oct; 66(20):10199-204. PubMed ID: 17047085 [TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of the sis and c-myc oncogenes in human meningiomas. Kazumoto K; Tamura M; Hoshino H; Yuasa Y J Neurosurg; 1990 May; 72(5):786-91. PubMed ID: 2182793 [TBL] [Abstract][Full Text] [Related]
14. PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss. Peyre M; Salaud C; Clermont-Taranchon E; Niwa-Kawakita M; Goutagny S; Mawrin C; Giovannini M; Kalamarides M Oncotarget; 2015 Oct; 6(32):32713-22. PubMed ID: 26418719 [TBL] [Abstract][Full Text] [Related]
15. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924 [TBL] [Abstract][Full Text] [Related]
16. [Observations on expression of c-fos and c-myc genes and activity of PDGFBB autocrine loop in 67 human gliomas]. Yu S; Pu P; Jiang D; Cheng Y; An T; Guan X Zhonghua Bing Li Xue Za Zhi; 1999 Jun; 28(3):182-6. PubMed ID: 11869525 [TBL] [Abstract][Full Text] [Related]
17. Correlation of histopathologic classification with proliferative activity and DNA ploidy in 120 intracranial meningiomas, with special reference to atypical meningioma. Myong NH; Chi JG J Korean Med Sci; 1997 Jun; 12(3):221-7. PubMed ID: 9250918 [TBL] [Abstract][Full Text] [Related]
18. The molecular biology of hormone and growth factor receptors in meningiomas. Black P; Carroll R; Zhang J Acta Neurochir Suppl; 1996; 65():50-3. PubMed ID: 8738495 [TBL] [Abstract][Full Text] [Related]
20. Histopathological parameters with Ki-67 and bcl-2 in the prognosis of meningiomas according to WHO 2000 classification. Uzüm N; Ataoğlu GA Tumori; 2008; 94(3):389-97. PubMed ID: 18705408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]